Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES)...
Saved in:
Published in | Korean circulation journal Vol. 47; no. 3; pp. 354 - 360 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Cardiology
01.05.2017
대한심장학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-5520 1738-5555 |
DOI | 10.4070/kcj.2016.0439 |
Cover
Abstract | There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD.
We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m
) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years.
Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001).
Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed. |
---|---|
AbstractList | There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD.BACKGROUND AND OBJECTIVESThere is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD.We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years.SUBJECTS AND METHODSWe analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years.Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001).RESULTSMedian follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001).Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.CONCLUSIONAmong patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed. Background and Objectives: There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD. Subjects and Methods: We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years. Results: Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79–1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77–1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85–4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57–1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20–6.96; p<0.001). Conclusion: Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed. KCI Citation Count: 3 There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD. We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m ) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9±9.1 years. Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [CI], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001). Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed. |
Author | Kang, Se Hun Yun, Sung-Cheol Lee, Pil Hyung Park, Seung-Jung Lee, Cheol Whan Park, Duk-Woo Ahn, Jung-Min Park, Seong-Wook Lee, Seung-Whan Kim, Young-Hak Kang, Soo-Jin |
AuthorAffiliation | 2 Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 1 Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea 3 Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: 3 Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – name: 1 Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea – name: 2 Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Se Hun surname: Kang fullname: Kang, Se Hun organization: Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea – sequence: 2 givenname: Cheol Whan surname: Lee fullname: Lee, Cheol Whan organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 3 givenname: Sung-Cheol surname: Yun fullname: Yun, Sung-Cheol organization: Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 4 givenname: Pil Hyung surname: Lee fullname: Lee, Pil Hyung organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 5 givenname: Jung-Min surname: Ahn fullname: Ahn, Jung-Min organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 6 givenname: Duk-Woo surname: Park fullname: Park, Duk-Woo organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 7 givenname: Soo-Jin surname: Kang fullname: Kang, Soo-Jin organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 8 givenname: Seung-Whan surname: Lee fullname: Lee, Seung-Whan organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 9 givenname: Young-Hak surname: Kim fullname: Kim, Young-Hak organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 10 givenname: Seong-Wook surname: Park fullname: Park, Seong-Wook organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 11 givenname: Seung-Jung surname: Park fullname: Park, Seung-Jung organization: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28567085$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227455$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNptks-PEyEUx4lZ4_7Qo1fDUQ9TgYFhuJh0u-vauEaj65kwDNPSTqECU9Pz_uNL2-1GjVwegc_7fnmPdw5OnHcGgNcYjSji6P1SL0YE4WqEaCmegTPMy7pgeZ087Qk6BecxLhCqKCXiBTglNas4qtkZuJ_44J0KWzgOyeRwuV2rGOFNUF2ybgY3cQSvwjArrvthf_AjGZfgdLXulUsqWe9g5wP8MvTJbkyMpodXNhoVDbQOfstE5iP8bdMcTubZzGr42bbObI_cS_C8U300rx7jBfj58fpu8qm4_XoznYxvC00JTkXT0VZpUxHNS9pg1iDVCsEIxw1uVV0aqpEWXVVpgktGSqFq1bS14owZRDkvL8C7g64LnVxqK72y-zjzchnk-PvdVOKSC1aRzH44sOuhWZlW5xqC6uU62FVu1j7z7xtn51lnIxml-U0iC7x9FAj-12Bikisbtelz14wfosQC0VqIGu-83vzp9WRy_KUMlAdABx9jMJ3U9tD6bG17iZHczUKuZSF3syB3s5Czin-yjsL_5x8AVRW4LA |
CitedBy_id | crossref_primary_10_1016_j_cpcardiol_2021_100886 crossref_primary_10_1093_icvts_ivaf021 crossref_primary_10_1186_s13019_020_01245_5 crossref_primary_10_1111_hdi_12946 crossref_primary_10_3389_fcvm_2022_802181 crossref_primary_10_1186_s12872_023_03560_w crossref_primary_10_1111_ijcp_14506 crossref_primary_10_1053_j_semtcvs_2020_11_005 crossref_primary_10_1159_000494116 crossref_primary_10_1007_s11886_021_01453_y crossref_primary_10_2459_JCM_0000000000001167 crossref_primary_10_4070_kcj_2017_0066 crossref_primary_10_4070_kcj_2017_0075 |
Cites_doi | 10.1056/NEJMoa040316 10.1161/01.CIR.96.6.1761 10.1046/j.1523-1755.1999.0550031057.x 10.1002/ccd.10103 10.1016/j.ahj.2004.10.010 10.1016/j.jacc.2016.04.034 10.1016/j.jacc.2015.06.1334 10.1016/S0735-1097(02)01745-X 10.1016/j.amjcard.2010.03.037 10.1161/CIRCULATIONAHA.105.580084 10.1016/S0735-1097(01)01450-4 10.1253/circj.CJ-08-0088 10.1161/CIRCULATIONAHA.107.750109 10.1161/CIRCULATIONAHA.105.591990 10.1161/CIR.0b013e31823a5596 10.1253/circj.CJ-08-1091 10.1016/j.jacc.2006.11.048 10.1056/NEJMoa071804 10.1093/ndt/12.4.718 10.1056/NEJMoa1211585 10.1161/CIRCULATIONAHA.107.688416 10.1016/S0140-6736(09)60552-3 10.1001/jama.2013.281718 10.1016/j.jacc.2004.12.082 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.jacc.2010.09.022 10.1161/CIR.0b013e31823c074e 10.1016/j.ahj.2005.03.018 |
ContentType | Journal Article |
Copyright | Copyright © 2017 The Korean Society of Cardiology 2017 |
Copyright_xml | – notice: Copyright © 2017 The Korean Society of Cardiology 2017 |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.4070/kcj.2016.0439 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1738-5555 |
EndPage | 360 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1379562 PMC5449529 28567085 10_4070_kcj_2016_0439 |
Genre | Journal Article |
GroupedDBID | --- 5-W 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EF. F5P HYE KQ8 M48 O5R O5S OK1 PGMZT RPM M~E NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c421t-bf4dace62c734b15b0ad995271b1da83e4c0c9f66c2135239a8abd8a755e04773 |
IEDL.DBID | M48 |
ISSN | 1738-5520 |
IngestDate | Tue Nov 21 21:45:40 EST 2023 Thu Aug 21 18:17:31 EDT 2025 Thu Jul 10 22:39:20 EDT 2025 Thu Jan 02 22:20:49 EST 2025 Tue Jul 01 02:56:54 EDT 2025 Thu Apr 24 23:04:11 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Renal insufficiency Percutaneous coronary intervention Coronary artery bypass Coronary disease |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c421t-bf4dace62c734b15b0ad995271b1da83e4c0c9f66c2135239a8abd8a755e04773 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4070/kcj.2016.0439 |
PMID | 28567085 |
PQID | 1904899812 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1379562 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5449529 proquest_miscellaneous_1904899812 pubmed_primary_28567085 crossref_citationtrail_10_4070_kcj_2016_0439 crossref_primary_10_4070_kcj_2016_0439 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-05-01 |
PublicationDateYYYYMMDD | 2017-05-01 |
PublicationDate_xml | – month: 05 year: 2017 text: 2017-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Korean circulation journal |
PublicationTitleAlternate | Korean Circ J |
PublicationYear | 2017 |
Publisher | The Korean Society of Cardiology 대한심장학회 |
Publisher_xml | – name: The Korean Society of Cardiology – name: 대한심장학회 |
References | Levine (10.4070/kcj.2016.0439_ref14) 2011; 124 Laskey (10.4070/kcj.2016.0439_ref17) 2007; 115 Hillis (10.4070/kcj.2016.0439_ref15) 2011; 124 Best (10.4070/kcj.2016.0439_ref2) 2002; 39 Park (10.4070/kcj.2016.0439_ref12) 2011; 57 Hannan (10.4070/kcj.2016.0439_ref16) 2008; 358 Hlatky (10.4070/kcj.2016.0439_ref24) 2009; 373 Chang (10.4070/kcj.2016.0439_ref26) 2016; 68 Lee (10.4070/kcj.2016.0439_ref6) 2008; 72 National Kidney Foundation (10.4070/kcj.2016.0439_ref19) 2002; 39 Javaid (10.4070/kcj.2016.0439_ref9) 2007; 116 Hannan (10.4070/kcj.2016.0439_ref8) 2005; 352 Gruberg (10.4070/kcj.2016.0439_ref20) 2002; 55 Wang (10.4070/kcj.2016.0439_ref29) 2009; 73 Cooper (10.4070/kcj.2016.0439_ref3) 2006; 113 Levey (10.4070/kcj.2016.0439_ref18) 2009; 150 Hillis (10.4070/kcj.2016.0439_ref4) 2006; 113 BARI Investigators (10.4070/kcj.2016.0439_ref23) 2007; 49 Farkouh (10.4070/kcj.2016.0439_ref25) 2012; 367 Ashrith (10.4070/kcj.2016.0439_ref28) 2010; 106 Serruys (10.4070/kcj.2016.0439_ref22) 2005; 46 Blackman (10.4070/kcj.2016.0439_ref1) 2006; 151 Shlipak (10.4070/kcj.2016.0439_ref5) 2001; 38 BARI Investigators (10.4070/kcj.2016.0439_ref10) 1997; 96 Bangalore (10.4070/kcj.2016.0439_ref30) 2015; 66 Deb (10.4070/kcj.2016.0439_ref27) 2013; 310 Ix (10.4070/kcj.2016.0439_ref11) 2005; 149 Anderson (10.4070/kcj.2016.0439_ref21) 1999; 55 Park (10.4070/kcj.2016.0439_ref13) 2008; 117 Joki (10.4070/kcj.2016.0439_ref7) 1997; 12 17433949 - J Am Coll Cardiol. 2007 Apr 17;49(15):1600-6 17470710 - Circulation. 2007 May 1;115(17):2352-7 15917382 - N Engl J Med. 2005 May 26;352(21):2174-83 26361150 - J Am Coll Cardiol. 2015 Sep 15;66(11):1209-20 18413495 - Circulation. 2008 Apr 22;117(16):2079-86 11923033 - J Am Coll Cardiol. 2002 Apr 3;39(7):1113-9 23121323 - N Engl J Med. 2012 Dec 20;367(25):2375-84 22064599 - Circulation. 2011 Dec 6;124(23):e652-735 20643244 - Am J Cardiol. 2010 Aug 1;106(3):348-53 17846304 - Circulation. 2007 Sep 11;116(11 Suppl):I200-6 16098418 - J Am Coll Cardiol. 2005 Aug 16;46(4):575-81 18216353 - N Engl J Med. 2008 Jan 24;358(4):331-41 10027944 - Kidney Int. 1999 Mar;55(3):1057-62 11793497 - Catheter Cardiovasc Interv. 2002 Jan;55(1):66-72 16490821 - Circulation. 2006 Feb 28;113(8):1063-70 21211683 - J Am Coll Cardiol. 2011 Jan 11;57(2):128-37 11527621 - J Am Coll Cardiol. 2001 Sep;38(3):705-11 19414839 - Ann Intern Med. 2009 May 5;150(9):604-12 27364047 - J Am Coll Cardiol. 2016 Jul 5;68(1):29-36 11904577 - Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266 9141000 - Nephrol Dial Transplant. 1997 Apr;12 (4):718-23 19303634 - Lancet. 2009 Apr 4;373(9670):1190-7 24240936 - JAMA. 2013 Nov 20;310(19):2086-95 15864241 - Am Heart J. 2005 Mar;149(3):512-9 22064598 - Circulation. 2011 Dec 6;124(23):2574-609 16490816 - Circulation. 2006 Feb 28;113(8):1056-62 9323059 - Circulation. 1997 Sep 16;96(6):1761-9 19443956 - Circ J. 2009 Jul;73(7):1228-34 18724014 - Circ J. 2008 Sep;72(9):1410-8 16368308 - Am Heart J. 2006 Jan;151(1):146-52 |
References_xml | – volume: 39 start-page: S1 issue: 2 Suppl 1 year: 2002 ident: 10.4070/kcj.2016.0439_ref19 publication-title: Am J Kidney Dis – volume: 352 start-page: 2174 year: 2005 ident: 10.4070/kcj.2016.0439_ref8 publication-title: N Engl J Med doi: 10.1056/NEJMoa040316 – volume: 96 start-page: 1761 year: 1997 ident: 10.4070/kcj.2016.0439_ref10 publication-title: Circulation doi: 10.1161/01.CIR.96.6.1761 – volume: 55 start-page: 1057 year: 1999 ident: 10.4070/kcj.2016.0439_ref21 publication-title: Kidney Int doi: 10.1046/j.1523-1755.1999.0550031057.x – volume: 55 start-page: 66 year: 2002 ident: 10.4070/kcj.2016.0439_ref20 publication-title: Catheter Cardiovasc Interv doi: 10.1002/ccd.10103 – volume: 149 start-page: 512 year: 2005 ident: 10.4070/kcj.2016.0439_ref11 publication-title: Am Heart J doi: 10.1016/j.ahj.2004.10.010 – volume: 68 start-page: 29 year: 2016 ident: 10.4070/kcj.2016.0439_ref26 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.04.034 – volume: 66 start-page: 1209 year: 2015 ident: 10.4070/kcj.2016.0439_ref30 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.06.1334 – volume: 39 start-page: 1113 year: 2002 ident: 10.4070/kcj.2016.0439_ref2 publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)01745-X – volume: 106 start-page: 348 year: 2010 ident: 10.4070/kcj.2016.0439_ref28 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2010.03.037 – volume: 113 start-page: 1063 year: 2006 ident: 10.4070/kcj.2016.0439_ref3 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.580084 – volume: 38 start-page: 705 year: 2001 ident: 10.4070/kcj.2016.0439_ref5 publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(01)01450-4 – volume: 72 start-page: 1410 year: 2008 ident: 10.4070/kcj.2016.0439_ref6 publication-title: Circ J doi: 10.1253/circj.CJ-08-0088 – volume: 117 start-page: 2079 year: 2008 ident: 10.4070/kcj.2016.0439_ref13 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.750109 – volume: 113 start-page: 1056 year: 2006 ident: 10.4070/kcj.2016.0439_ref4 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.591990 – volume: 124 start-page: 2574 year: 2011 ident: 10.4070/kcj.2016.0439_ref14 publication-title: Circulation doi: 10.1161/CIR.0b013e31823a5596 – volume: 73 start-page: 1228 year: 2009 ident: 10.4070/kcj.2016.0439_ref29 publication-title: Circ J doi: 10.1253/circj.CJ-08-1091 – volume: 49 start-page: 1600 year: 2007 ident: 10.4070/kcj.2016.0439_ref23 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.11.048 – volume: 358 start-page: 331 year: 2008 ident: 10.4070/kcj.2016.0439_ref16 publication-title: N Engl J Med doi: 10.1056/NEJMoa071804 – volume: 12 start-page: 718 year: 1997 ident: 10.4070/kcj.2016.0439_ref7 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/12.4.718 – volume: 367 start-page: 2375 year: 2012 ident: 10.4070/kcj.2016.0439_ref25 publication-title: N Engl J Med doi: 10.1056/NEJMoa1211585 – volume: 115 start-page: 2352 year: 2007 ident: 10.4070/kcj.2016.0439_ref17 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.688416 – volume: 373 start-page: 1190 year: 2009 ident: 10.4070/kcj.2016.0439_ref24 publication-title: Lancet doi: 10.1016/S0140-6736(09)60552-3 – volume: 310 start-page: 2086 year: 2013 ident: 10.4070/kcj.2016.0439_ref27 publication-title: JAMA doi: 10.1001/jama.2013.281718 – volume: 46 start-page: 575 year: 2005 ident: 10.4070/kcj.2016.0439_ref22 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2004.12.082 – volume: 150 start-page: 604 year: 2009 ident: 10.4070/kcj.2016.0439_ref18 publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 – volume: 57 start-page: 128 year: 2011 ident: 10.4070/kcj.2016.0439_ref12 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.09.022 – volume: 124 start-page: e652 year: 2011 ident: 10.4070/kcj.2016.0439_ref15 publication-title: Circulation doi: 10.1161/CIR.0b013e31823c074e – volume: 151 start-page: 146 year: 2006 ident: 10.4070/kcj.2016.0439_ref1 publication-title: Am Heart J doi: 10.1016/j.ahj.2005.03.018 – volume: 116 start-page: I200 issue: 11 Suppl year: 2007 ident: 10.4070/kcj.2016.0439_ref9 publication-title: Circulation – reference: 17470710 - Circulation. 2007 May 1;115(17):2352-7 – reference: 16490816 - Circulation. 2006 Feb 28;113(8):1056-62 – reference: 18216353 - N Engl J Med. 2008 Jan 24;358(4):331-41 – reference: 10027944 - Kidney Int. 1999 Mar;55(3):1057-62 – reference: 24240936 - JAMA. 2013 Nov 20;310(19):2086-95 – reference: 26361150 - J Am Coll Cardiol. 2015 Sep 15;66(11):1209-20 – reference: 11904577 - Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266 – reference: 22064599 - Circulation. 2011 Dec 6;124(23):e652-735 – reference: 21211683 - J Am Coll Cardiol. 2011 Jan 11;57(2):128-37 – reference: 16098418 - J Am Coll Cardiol. 2005 Aug 16;46(4):575-81 – reference: 20643244 - Am J Cardiol. 2010 Aug 1;106(3):348-53 – reference: 18724014 - Circ J. 2008 Sep;72(9):1410-8 – reference: 11527621 - J Am Coll Cardiol. 2001 Sep;38(3):705-11 – reference: 17846304 - Circulation. 2007 Sep 11;116(11 Suppl):I200-6 – reference: 27364047 - J Am Coll Cardiol. 2016 Jul 5;68(1):29-36 – reference: 11793497 - Catheter Cardiovasc Interv. 2002 Jan;55(1):66-72 – reference: 22064598 - Circulation. 2011 Dec 6;124(23):2574-609 – reference: 19303634 - Lancet. 2009 Apr 4;373(9670):1190-7 – reference: 19414839 - Ann Intern Med. 2009 May 5;150(9):604-12 – reference: 17433949 - J Am Coll Cardiol. 2007 Apr 17;49(15):1600-6 – reference: 9323059 - Circulation. 1997 Sep 16;96(6):1761-9 – reference: 9141000 - Nephrol Dial Transplant. 1997 Apr;12 (4):718-23 – reference: 19443956 - Circ J. 2009 Jul;73(7):1228-34 – reference: 23121323 - N Engl J Med. 2012 Dec 20;367(25):2375-84 – reference: 11923033 - J Am Coll Cardiol. 2002 Apr 3;39(7):1113-9 – reference: 16368308 - Am Heart J. 2006 Jan;151(1):146-52 – reference: 18413495 - Circulation. 2008 Apr 22;117(16):2079-86 – reference: 15917382 - N Engl J Med. 2005 May 26;352(21):2174-83 – reference: 16490821 - Circulation. 2006 Feb 28;113(8):1063-70 – reference: 15864241 - Am Heart J. 2005 Mar;149(3):512-9 |
SSID | ssj0064429 |
Score | 2.126092 |
Snippet | There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel... Background and Objectives: There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD)... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 354 |
SubjectTerms | Original 내과학 |
Title | Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28567085 https://www.proquest.com/docview/1904899812 https://pubmed.ncbi.nlm.nih.gov/PMC5449529 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227455 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Korean Circulation Journal, 2017, 47(3), , pp.354-360 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1dT9swFLX4kNBeJmBsdAxkpomnpYsdO06eEN9sUxESq8Sb5Tgu66hcSFtEn_fHuTdJC2VM4ilRciNLOXbuOfH1MSFfwk6OzMEGBnIDCBQbwZmNA5maJAM6YpLSial1Fp-2xY9LefloKVS_wMGL0g73k2oXveb97XgXBjzw1ybIkfDbtf2DNVpxE5d5zpNFSEox6rCWmE4oQNYvNyxjCsa3lDys7Db_fXwmPc37ovMS83xeQPkkIx0vk7c1laR7FfYrZM75VbLUqifL35G_B-hOYIoxhjg47I9vgCrTk8J0sNiZ3g2a9LAYXQVH2P3gwgUQ6CFFw2BTrUjyFDgtLRfp3qHJeI8eVhM6tOvpeWXJOqD4L5fWLrv0Zzf3bjyJWyPt46NfB6dBvedCYAVnwwDr9ox1MbcqEhmTWWjyNJVcsYzlJomcsKFNO3FsOQPuFgGkJssTo6R0oVAqek8WfN-7dUIFkLsoMTIXPBSGMwOfC-syy2wu4UuRNcjXyavWtjYkx30xehqECSKjARmNyGhEpkF2puE3lRPH_wI_A25wravROxuPV319XWhQCN81ixRIQt4g2xNYNQwonCUx3vVHAw0MSaAIZRDzoYJ52h5PZKyApDaImukA0wBscPaO7_4uTbulACnK04-vaHeDvOFIHsqyyk9kYViM3CZQn2G2VXbqB1CHAxU |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronary+Artery+Bypass+Grafting+vs.+Drug-Eluting+Stent+Implantation+for+Multivessel+Disease+in+Patients+with+Chronic+Kidney+Disease&rft.jtitle=Korean+circulation+journal&rft.au=Kang%2C+Se+Hun&rft.au=Lee%2C+Cheol+Whan&rft.au=Yun%2C+Sung-Cheol&rft.au=Lee%2C+Pil+Hyung&rft.date=2017-05-01&rft.issn=1738-5520&rft.volume=47&rft.issue=3&rft.spage=354&rft_id=info:doi/10.4070%2Fkcj.2016.0439&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-5520&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-5520&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-5520&client=summon |